Publications by authors named "Sandra A Moore"

Claim this Profile
T
The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model.
Thomas Mercher, Glen D Raffel, Sandra A Moore, Melanie G Cornejo, Dominique Baudry-Bluteau

J Clin Invest· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models.
Melanie G Cornejo, Michael G Kharas, Miriam B Werneck, Séverine Le Bras, Sandra A Moore

Blood· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Notch signaling specifies megakaryocyte development from hematopoietic stem cells.
Thomas Mercher, Melanie G Cornejo, Christopher Sears, Thomas Kindler, Sandra A Moore

Cell Stem Cell· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera.
Gerlinde Wernig, Michael G Kharas, Rachel Okabe, Sandra A Moore, Dena S Leeman

Cancer Cell· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model.
Thomas Mercher, Gerlinde Wernig, Sandra A Moore, Ross L Levine, Ting-Lei Gu

Blood· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activating alleles of JAK3 in acute megakaryoblastic leukemia.
Denise K Walters, Thomas Mercher, Ting-Lei Gu, Thomas O'Hare, Jeffrey W Tyner, Sandra A Moore

Cancer Cell· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFRbeta and FIP1L1-PDGFRalpha in vitro and in vivo.
Elizabeth H Stover, Jing Chen, Benjamin H Lee, Jan Cools, Elizabeth McDowell, Sandra A Moore

Blood· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis